Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review

O Leiva, D AbdelHameid, JM Connors, CP Cannon… - Cardio Oncology, 2021 - jacc.org
Cardiovascular disease and cancer are the 2 leading causes of death worldwide. Emerging
evidence suggests common mechanisms between cancer and cardiovascular disease …

Insights into onco-cardiology: atrial fibrillation in cancer

D Farmakis, J Parissis, G Filippatos - Journal of the American College of …, 2014 - jacc.org
Atrial fibrillation (AF) has been found to occur with an increased frequency in patients with
malignancies, particularly in those undergoing cancer surgery. The occurrence of AF in …

Cardio-oncology: a myriad of relationships between cardiovascular disease and cancer

Y Wang, Y Wang, X Han, J Sun, C Li… - Frontiers in …, 2022 - frontiersin.org
Cardiovascular disease (CVD) and cancer are the leading causes of death worldwide. With
an increasing number of the elderly population, and early cancer screening and treatment …

Atrial fibrillation in active cancer patients: expert position paper and recommendations

T Lopez-Fernandez, A Martin-Garcia… - Revista Española de …, 2019 - Elsevier
Improvements in survival among cancer patients have revealed the clinical impact of
cardiotoxicity on both cardiovascular and hematological and oncological outcomes …

Atrial fibrillation and cancer–an unexplored field in cardiovascular oncology

G Chu, HH Versteeg, AJ Verschoor, SA Trines… - Blood reviews, 2019 - Elsevier
An increasing body of evidence suggests an association between cancer and atrial
fibrillation (AF). The exact magnitude and underlying mechanism of this association are …

Cardio-oncology-strategies for management of cancer-therapy related cardiovascular disease

M Totzeck, M Schuler, M Stuschke, G Heusch… - International Journal of …, 2019 - Elsevier
Current therapy of advanced cancers is based on several modalities including radiotherapy,
cytotoxic chemotherapy, molecularly targeted inhibitors and antibodies targeting immune …

Cardio-oncology: vascular and metabolic perspectives: a scientific statement from the American Heart Association

U Campia, JJ Moslehi, L Amiri-Kordestani, A Barac… - Circulation, 2019 - Am Heart Assoc
Cardio-oncology has organically developed as a new discipline within cardiovascular
medicine as a result of the cardiac and vascular adverse sequelae of the major advances in …

Shared risk factors in cardiovascular disease and cancer

RJ Koene, AE Prizment, A Blaes, SH Konety - Circulation, 2016 - Am Heart Assoc
Cardiovascular disease (CVD) and cancer are the 2 leading causes of death worldwide.
Although commonly thought of as 2 separate disease entities, CVD and cancer possess …

Cancer as a risk factor for cardiovascular disease

DE Giza, G Iliescu, S Hassan, K Marmagkiolis… - Current oncology …, 2017 - Springer
Improvements in early diagnosis and cancer treatments have contributed to high survival
rates for many cancer patients. However, these patients often die of cardiovascular disease …

Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study

D Pastori, A Marang, A Bisson, D Menichelli… - Cancer, 2021 - Wiley Online Library
Background The number of patients with atrial fibrillation (AF) and cancer is rapidly
increasing in clinical practice. The impact of cancer on clinical outcomes in this patient …